Results of the scoring systems revealed that all markers exhibited high expression in both the groups (Table 4), indicating that the PI3K/AKT/mTOR signaling pathway was highly activated in patients with HNSCC. This evidence concerns the gene MTOR and head and neck squamous cell carcinoma.